Rawad Elias

4.0k total citations
28 papers, 535 citations indexed

About

Rawad Elias is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Geriatrics and Gerontology. According to data from OpenAlex, Rawad Elias has authored 28 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 8 papers in Geriatrics and Gerontology. Recurrent topics in Rawad Elias's work include Cancer Immunotherapy and Biomarkers (13 papers), Frailty in Older Adults (8 papers) and Pancreatic and Hepatic Oncology Research (6 papers). Rawad Elias is often cited by papers focused on Cancer Immunotherapy and Biomarkers (13 papers), Frailty in Older Adults (8 papers) and Pancreatic and Hepatic Oncology Research (6 papers). Rawad Elias collaborates with scholars based in United States, Australia and Lebanon. Rawad Elias's co-authors include Kevan L. Hartshorn, Osama E. Rahma, Theodoros Karantanos, Anita Giobbie‐Hurder, F. Stephen Hodi, Patrick A. Ott, Nadine J. McCleary, Nina Lin, Jennifer Snyder‐Cappione and Humera Khurshid and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of the American Geriatrics Society.

In The Last Decade

Rawad Elias

28 papers receiving 531 citations

Peers

Rawad Elias

ONCOL

PRM

IMMUN

PHYSI

Jukes P. Namm United States

Maxime Frélaut France

Andrea Corkhill United Kingdom

Scott A. Soefje United States

B. Castagneto Italy

Muhammed Bülent Akıncı Türkiye

Smita Kayal India

Alistair Ring United Kingdom

Caroleen Quach United States

Madison Grogan United States

Jukes P. Namm United States

Rawad Elias

240 ×0.6

ONCOL

89 ×0.6

PRM

67 ×0.5

IMMUN

38 ×0.6

57 ×1.1

PHYSI

Citations per year, relative to Rawad Elias Rawad Elias (= 1×) peers Jukes P. Namm

Countries citing papers authored by Rawad Elias

Since Specialization

Citations

This map shows the geographic impact of Rawad Elias's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rawad Elias with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rawad Elias more than expected).

Fields of papers citing papers by Rawad Elias

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rawad Elias. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rawad Elias. The network helps show where Rawad Elias may publish in the future.

Co-authorship network of co-authors of Rawad Elias

This figure shows the co-authorship network connecting the top 25 collaborators of Rawad Elias. A scholar is included among the top collaborators of Rawad Elias based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rawad Elias. Rawad Elias is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Loh, Kah Poh, et al.. (2024). Geriatric Oncology: A 5-Year Strategic Plan. American Society of Clinical Oncology Educational Book. 44(3). e100044–e100044. 6 indexed citations

Katz, Matthew H. G., Gina R. Petroni, Todd W. Bauer, et al.. (2023). Multicenter randomized controlled trial of neoadjuvant chemoradiotherapy alone or in combination with pembrolizumab in patients with resectable or borderline resectable pancreatic adenocarcinoma. Journal for ImmunoTherapy of Cancer. 11(12). e007586–e007586. 18 indexed citations

Kudelka, Matthew R., Ghassan K. Abou‐Alfa, Eileen M. O’Reilly, et al.. (2023). Metastatic well differentiated serotonin-producing pancreatic neuroendocrine tumor with carcinoid heart disease: a case report. Journal of Gastrointestinal Oncology. 14(4). 1878–1886. 1 indexed citations

Sheikh, Ayesha, Michael J. Dennis, Andrew Hunter, et al.. (2022). The impact of substance use on health care utilization, treatment, and outcomes in patients with non-small cell lung cancer. Journal of Thoracic Disease. 14(10). 3865–3875. 5 indexed citations

Dika, Imane El, Jinru Shia, Carol L. Chen, et al.. (2022). Congenital cardiac liver cirrhosis with combined hepatocellular-cholangiocarcinoma—a case report. Journal of Gastrointestinal Oncology. 13(6). 3321–3328. 1 indexed citations

Ozcan, Gonca, Catriona B. Hong, Nicole M. Mott, et al.. (2022). Home-based geriatric oncology care: A feasibility study.. Journal of Clinical Oncology. 40(28_suppl). 62–62. 1 indexed citations

Rahma, Osama E., Matthew H. G. Katz, Brian M. Wolpin, et al.. (2021). Randomized multicenter phase Ib/II study of neoadjuvant chemoradiation therapy (CRT) alone or in combination with pembrolizumab in patients with resectable or borderline resectable pancreatic cancer.. Journal of Clinical Oncology. 39(15_suppl). 4128–4128. 10 indexed citations

Rosko, Ashley, Christopher Steer, Leana Cabrera Chien, et al.. (2021). The Cancer and Aging Research Group (CARG) infrastructure: The clinical implementation core. Journal of Geriatric Oncology. 12(8). 1164–1165. 5 indexed citations

Klepin, Heidi D., Can‐Lan Sun, David Smith, et al.. (2021). Predictors of Unplanned Hospitalizations Among Older Adults Receiving Cancer Chemotherapy. JCO Oncology Practice. 17(6). e740–e752. 20 indexed citations

10.

Grover, Shilpa, Michael Dougan, Ryan J. Sullivan, et al.. (2020). Association of vitamin D intake with decreased risk of immune checkpoint inhibitor-induced colitis.. Journal of Clinical Oncology. 38(5_suppl). 89–89. 4 indexed citations

11.

Magnuson, Allison, Rawad Elias, & Thuy T. Koll. (2019). Expanding Therapeutic Options for Older Adults: Case‐Based Updates in Breast and Lung Cancer. Journal of the American Geriatrics Society. 67(5). 1012–1019. 2 indexed citations

12.

Elias, Rawad & Oreofe O. Odejide. (2019). Immunotherapy in Older Adults: A Checkpoint to Palliation?. American Society of Clinical Oncology Educational Book. 39(39). e110–e120. 16 indexed citations

13.

Elias, Rawad, Kah Poh Loh, Valerie Targia, et al.. (2019). Behavioral, psychological, and supportive care interventions in geriatric oncology: The Cancer and Aging Research Group infrastructure core. Journal of Geriatric Oncology. 11(2). 347–349. 5 indexed citations

14.

Hernández-Tejedor, A., et al.. (2019). 3 CPR by first responders improves acid-base balance and prognosis in out-of-hospital non-traumatic cardiac arrest. Abstracts. A1.3–A2. 3 indexed citations

15.

Elias, Rawad, Anita Giobbie‐Hurder, Nadine J. McCleary, et al.. (2018). Efficacy of PD-1 & PD-L1 inhibitors in older adults: a meta-analysis. Journal for ImmunoTherapy of Cancer. 6(1). 26–26. 153 indexed citations

16.

Elias, Rawad, Kevan L. Hartshorn, Osama E. Rahma, Nina Lin, & Jennifer Snyder‐Cappione. (2018). Aging, immune senescence, and immunotherapy: A comprehensive review. Seminars in Oncology. 45(4). 187–200. 64 indexed citations

17.

Elias, Rawad, et al.. (2018). Ibrutinib: A post-marketing safety analysis.. Journal of Clinical Oncology. 36(15_suppl). e19559–e19559. 1 indexed citations

18.

Elias, Rawad, et al.. (2017). Immunotherapy comes of age: Immune aging & checkpoint inhibitors. Journal of Geriatric Oncology. 8(3). 229–235. 116 indexed citations

19.

Elias, Rawad, et al.. (2017). Checkpoint Inhibitors for Non-Small Cell Lung Cancer Among Older Adults. Current Oncology Reports. 19(9). 62–62. 18 indexed citations

20.

Elias, Rawad, et al.. (2016). Immune Checkpoint Inhibitors in Older Adults. Current Oncology Reports. 18(8). 47–47. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact